Bourgeon Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-283
Closed -$22.5K 152
2023
Q4
$22.5K Buy
283
+2
+0.7% +$150 0.01% 200
2023
Q3
$20K Buy
281
+2
+0.7% +$150 ﹤0.01% 198
2023
Q2
$21.5K Buy
279
+2
+0.7% +$155 0.01% 208
2023
Q1
$20.8K Buy
277
+1
+0.4% +$74 0.01% 192
2022
Q4
$21.7K Buy
276
+2
+0.7% +$150 0.01% 195
2022
Q3
$19K Buy
274
+2
+0.7% +$157 0.01% 180
2022
Q2
$22K Buy
272
+1
+0.4% +$78 0.01% 176
2022
Q1
$21K Buy
271
+2
+0.7% +$158 ﹤0.01% 188
2021
Q4
$23K Buy
269
+1
+0.4% +$78 ﹤0.01% 180
2021
Q3
$20K Buy
268
+2
+0.8% +$159 ﹤0.01% 203
2021
Q2
$22K Buy
266
+1
+0.4% +$82 ﹤0.01% 196
2021
Q1
$21K Buy
265
+2
+0.8% +$157 ﹤0.01% 194
2020
Q4
$23K Buy
263
+1
+0.4% +$83 0.01% 173
2020
Q3
$20K Buy
262
+2
+0.8% +$152 0.01% 185
2020
Q2
$19K Buy
260
+1
+0.4% +$71 0.01% 165
2020
Q1
$17K Buy
259
+2
+0.8% +$141 0.01% 154
2019
Q4
$18K Buy
257
+1
+0.4% +$68 0.01% 154
2019
Q3
$19K Buy
+256
New +$18.6K 0.01% 151

Other funds holding CL

Bourgeon Capital Management's CL Position: Q1 2024 in Review

Bourgeon Capital Management sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 283 shares — an estimated $22.5K sold.

Bourgeon Capital Management first reported a position in CL in Q3 2019 and held it in 18 quarters. The position peaked at $23K in Q4 2021. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Bourgeon Capital Management reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Bourgeon Capital Management sold 283 Colgate-Palmolive shares in Q1 2024, an estimated $22.5K.
  • Bourgeon Capital Management first reported a position in Colgate-Palmolive in Q3 2019 and held it in 18 quarters.
  • Bourgeon Capital Management's Colgate-Palmolive position peaked at $23K in Q4 2021.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Bourgeon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.